Aditya Basu

EN | BioFlux - The Brief (English)

News EN ↓ Епізодів: 27

NexTechie BioFlux: Tracking the Tech That Heals, Evolves, and Informs. Biotechnology and health innovation are transforming the way we live, heal, and understand the human body. NexTechie BioFlux – The Brief delivers clarity, speed, and authority in a rapid 3‑minute audio overview designed for professionals, innovators, and decision‑makers who need to stay ahead of the biotech frontier. Every episode distills the most important breakthroughs, platforms, and strategies into a concise briefing that respects your time while expanding your perspective. BioFlux is more than just a podcast—it’s a st...

Обов'язково відвідайте сайт подкасту та підтримайте його автора: vip.nextechie.in

Автор

Aditya Basu

Категорія

News

Сайт подкасту

vip.nextechie.in

Останній епізод

7 жов 2026

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Встановіть безкоштовно Android майже 10 млн завантажень · рейтинг 4,8 iOS незабаром

Епізоди

NexTechie BioFLux - The Brief: Ubiquitous AI Clinician Transforming Diagnostics, Drug Discovery, and Delivery 21.11.2025 2:52

In this edition, we dissect the explosive impact of Artificial Intelligence across the entire healthcare continuum. We begin with our central theme, exploring how AI is making a monumental diagnostic leap, evolving everyday tools like the stethoscope into powerful real-time analyzers and revolutionizing how we interpret complex imaging for conditions like stroke and heart disease. Subscribe to the...

NexTechie BioFlux - The Brief: Asset-Centric Biotech Funding, Rise of AI in Diagnostics and Surgery, FDA's New Path for Bespoke Therapies 15.11.2025 2:19

Welcome to NexTechie BioFlux - The Brief. Your smart dive into tech that heals, evolves, and informs. In this edition, we dissect Medicxi's landmark €500M fund and what its 'asset-centric' strategy means for the entire innovation pipeline. We then pivot to groundbreaking developments across the sectors, from generative AI platforms that outperform doctors in complex diagnostics to next-generation...